Physician profile
Stephan B Simons
NPI 1710928304
$4,076.30
in general payments reported to CMS, 2019-2025
23 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $759 · 2021: $940 · 2022: $651 · 2023: $551 · 2024: $284 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.95 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $852.88 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $729.23 | 2019-2024 | Shingrix, Bexsero, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $622.89 | 2020-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals Lp | $384.85 | 2019-2025 | Farxiga |
| Pfizer INC. | $234.56 | 2019-2025 | |
| Amgen INC. | $222.55 | 2019-2025 | Otezla, Repatha |
| Abbott Laboratories | $201.87 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $185.20 | 2019-2021 | |
| Exact Sciences Corporation | $125.81 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mylan Specialty L.P. | $85.99 | 2019-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.35 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $63.14 | 2020-2022 | |
| Astellas Pharma US INC | $49.25 | 2023 | Myrbetriq, Veozah |
| Lilly USA, LLC | $45.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $43.96 | 2024-2025 | Camzyos |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $32.94 | 2019 | |
| Nestle Healthcare Nutrition INC. | $23.39 | 2020 | |
| Horizon Therapeutics Plc | $20.22 | 2019 | |
| Renalytix Ai, INC. | $20.21 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Circassia INC. | $15.33 | 2019 | |
| Esperion Therapeutics, INC. | $15.28 | 2021 | |
| Phadia US INC. | $12.94 | 2022 | |
| Vifor Pharma, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.